vigabatrin has been researched along with Dyskinesia, Medication-Induced in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Vigabatrin was specifically designed to enhance gamma-aminobutyric acid (GABA) function in the CNS." | 7.77 | Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. ( Grant, SM; Heel, RC, 1991) |
| "Vigabatrin was specifically designed to enhance gamma-aminobutyric acid (GABA) function in the CNS." | 3.77 | Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. ( Grant, SM; Heel, RC, 1991) |
| "Acute and chronic administration of vigabatrin, a selective inactivator of GABA-T, suppresses haloperidol-induced dyskinesias at low doses without preventing the enhancement of striatal dopamine D2 receptor density or the development of vacuous chewing movements." | 1.29 | Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin. ( Elands, J; Gobaille, S; Grauffel, C; Knödgen, B; Moran, P; Sarhan, S; Seiler, N; van den Buuse, M, 1995) |
| "Tetrahydroisoxazolopyridinol (THIP), a GABA receptor agonist, gamma-acetylenic-GABA(GAG) and gamma-vinyl-GABA(GVG), two GABA transaminase inhibitors were given in single parenteral doses to three Cebus apella monkeys with persistent dyskinetic movements induced by earlier long-term administration of haloperidol." | 1.27 | GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias. ( Andersson, U; Häggström, JE, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (76.47) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, LR | 1 |
| Bosemani, T | 1 |
| Smith-Hicks, CL | 1 |
| Gale, K | 1 |
| Casu, M | 1 |
| Tamminga, CA | 3 |
| Thaker, GK | 3 |
| Ferraro, TN | 2 |
| Hare, TA | 3 |
| Korsgaard, S | 1 |
| Casey, DE | 1 |
| Gerlach, J | 1 |
| Lambert, PA | 2 |
| Cantiniaux, P | 2 |
| Chabannes, JP | 2 |
| Tell, GP | 2 |
| Schechter, PJ | 2 |
| Koch-Weser, J | 2 |
| Danion, JM | 1 |
| Singer, L | 1 |
| Tell, G | 1 |
| Schechter, P | 1 |
| Seiler, N | 1 |
| Grauffel, C | 1 |
| Elands, J | 1 |
| van den Buuse, M | 1 |
| Knödgen, B | 1 |
| Sarhan, S | 1 |
| Moran, P | 1 |
| Gobaille, S | 1 |
| Turjanski, N | 1 |
| Lees, AJ | 1 |
| Grant, SM | 1 |
| Heel, RC | 1 |
| Andersson, U | 1 |
| Häggström, JE | 1 |
| Hammond, EJ | 2 |
| Wilder, BJ | 2 |
| Alphs, LD | 1 |
| Lafferman, J | 1 |
| Gaio, JM | 1 |
| Pollak, P | 1 |
| Hommel, M | 1 |
| Perret, J | 1 |
| Stahl, SM | 1 |
| Thornton, JE | 1 |
| Simpson, ML | 1 |
| Berger, PA | 1 |
| Napoliello, MJ | 1 |
5 reviews available for vigabatrin and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
Topics: 4-Aminobutyrate Transaminase; Afferent Pathways; Aminocaproates; Animals; Basal Ganglia; Behavior, A | 1981 |
GABA system: clinical research and treatment of tardive dyskinesia.
Topics: Alkynes; Aminocaproates; Benzodiazepines; Clinical Trials as Topic; Corpus Striatum; Dopamine; Dyski | 1983 |
Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Aminocaproates; Animals; Ataxia; Child; Dyskinesia, Drug- | 1991 |
Gamma-vinyl GABA.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Aminocaproates; Animals; Behavior, Animal; beta-Alanine; | 1985 |
Gamma-vinyl GABA: a new antiepileptic drug.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Aminocaproates; Animals; Anticonvulsants; Brain Chemistry | 1985 |
7 trials available for vigabatrin and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
GABA agonist treatment improves tardive dyskinesia.
Topics: 4-Aminobutyrate Transaminase; Aminocaproates; Clinical Trials as Topic; Double-Blind Method; Dyskine | 1983 |
[Therapeutic trial of gamma-vinyl GABA, an inhibitor of GABA transaminase, in tardive dyskinesias induced by neuroleptics].
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Aminocaproates; Antipsychotic Agents; Clinical Trials as | 1982 |
GABA system: clinical research and treatment of tardive dyskinesia.
Topics: Alkynes; Aminocaproates; Benzodiazepines; Clinical Trials as Topic; Corpus Striatum; Dopamine; Dyski | 1983 |
[Gamma-vinyl GABA and tardive dyskinesia: a single-blind study versus placebo].
Topics: 4-Aminobutyrate Transaminase; Adolescent; Adult; Aged; Aminocaproates; Drug Evaluation; Dyskinesia, | 1984 |
Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control.
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Aminocaproates; Animals; Ataxia; Child; Dyskinesia, Drug- | 1991 |
Brain gamma-aminobutyric acid abnormality in tardive dyskinesia. Reduction in cerebrospinal fluid GABA levels and therapeutic response to GABA agonist treatment.
Topics: Adult; Aminocaproates; Brain; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induce | 1987 |
Gamma-vinyl GABA: a new antiepileptic drug.
Topics: 4-Aminobutyrate Transaminase; Amino Acids; Aminocaproates; Animals; Anticonvulsants; Brain Chemistry | 1985 |
8 other studies available for vigabatrin and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Neuroimaging Abnormalities in a Child With Infantile Spasms on High-Dose Vigabatrin.
Topics: Developmental Disabilities; Down Syndrome; Dyskinesia, Drug-Induced; Female; GABA Agents; Humans; In | 2017 |
Effect of gamma-vinyl GABA in tardive dyskinesia.
Topics: Adult; Aged; Aminocaproates; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Ag | 1983 |
Effects of gamma-vinyl GABA.
Topics: Aminocaproates; Dyskinesia, Drug-Induced; Humans; Vigabatrin | 1981 |
Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin.
Topics: 4-Aminobutyrate Transaminase; Animals; Anticonvulsants; Body Weight; Brain; Dyskinesia, Drug-Induced | 1995 |
Gamma vinyl GABA in the treatment of levodopa-induced dyskinesias in Parkinson's disease.
Topics: 4-Aminobutyrate Transaminase; Adult; Aged; Aminocaproates; Chorea; Dose-Response Relationship, Drug; | 1992 |
GABA agonists in cebus monkeys with neuroleptic-induced persistent dyskinesias.
Topics: 4-Aminobutyrate Transaminase; Alkynes; Aminocaproates; Animals; Antipsychotic Agents; Cebus; Dyskine | 1988 |
Clinical and biochemical effects of gamma-vinyl Gaba in tardive dyskinesia.
Topics: Aged; Aminocaproates; Carnosine; Dyskinesia, Drug-Induced; gamma-Aminobutyric Acid; Humans; Mental D | 1987 |
Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
Topics: Adult; Aged; Aminocaproates; Confusion; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; H | 1985 |